Robert S. Mills's most recent trade in Tff Pharmaceuticals Inc was a trade of 3,165 Stock Options (Right to Buy) done . Disclosure was reported to the exchange on July 3, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tff Pharmaceuticals Inc | Robert S. Mills | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2024 | 3,165 | 3,165 | - | - | Stock Options (Right to Buy) | |
| Tff Pharmaceuticals Inc | Robert S. Mills | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2024 | 3,165 | 59,145 (0%) | 0% | 0 | Common Stock | |
| Tff Pharmaceuticals Inc | Robert S. Mills | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Apr 2024 | 4,667 | 4,667 | - | - | Restricted stock units | |
| Tff Pharmaceuticals Inc | S. Robert Mills | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2023 | 52,858 | 52,858 | - | - | Stock Options (Right to Buy) | |
| Tff Pharmaceuticals Inc | Robert S. Mills | Director | Purchase of securities on an exchange or from another person at price $ 0.25 per share. | 15 Aug 2023 | 40,000 | 55,980 (0%) | 0% | 0.3 | 10,000 | Common Stock |